Comparison of the efficacy and side effects of intravenous-arterial fistula methods in hemodialysis
Phase 3
- Conditions
- Kidney failure.Chronic kidney disease, stage 5N18, N18.5
- Registration Number
- IRCT20200217046525N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 85
Inclusion Criteria
Patient with hemodialysis
Patient with fistula implantation in elbow (including inappropriate vein or artery in wrist, previous failure of fistula in wrist)
Patient's consent to participate in the study
No intravenous injection into the elbow area at least two weeks before surgery
Systolic blood pressure above 110 mm Hg before surgery
Exclusion Criteria
Fistula embolization due to underlying vascular problems (calcification and venous thrombosis)
Inability to perform fistula without displacement due to venous topography
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Early efficacy of intravenous arterial fistula. Timepoint: Every two weeks until preparation for dialysis. Method of measurement: Physical examination by using checklists.
- Secondary Outcome Measures
Name Time Method ate efficacy of intravenous arterial fistula. Timepoint: Day after surgery, one week after surgery and 12 weeks after surgery. Method of measurement: Measurement of blood flow at the fistula site.;Steel Syndrome and Functional Deficiency. Timepoint: Day after surgery, one week after surgery and 12 weeks after surgery. Method of measurement: Physical examination.